GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Zimmer Holdings, Inc. (ZBH) [hlAlert]

Rating:
Hold ZMH
up 24.51 %

Zimmer Holdings, Inc. (ZMH) downgraded to Hold by Stifel Nicolaus

Posted on: Tuesday,  Nov 20, 2012  9:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Hold Zimmer Holdings, Inc. (NYSE: ZBH) on 11/20/2012. Previously Stifel Nicolaus rated Buy Zimmer Holdings, Inc. (NYSE: ZBH) on
01/07/2011., when the stock price was $52.59. Since then, Zimmer Holdings, Inc. has gained 24.51% as of 11/20/2012's recent price of $65.48.
If you would have followed the previous Stifel Nicolaus's recommendation on ZBH, you would have gained 24.51% of your investment in 683 days.

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Its primary customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent surgeons. It has operations in more than 25 countries and market products in more than 100 countries. In October 2008, the Company acquired Abbott Spine. It markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and, in the Asia Pacific region, healthcare dealers, and directly to dental practices and dental laboratories.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2012 9:25 AM Hold
None
65.48
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/7/2011 9:25 AM Buy
None
52.59 60.00
9/2/2010 8:25 AM Buy
None
47.99 58.00
10/24/2008 8:25 AM Buy
None
40.57 61.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy